DSC Advisors’s Emergent Biosolutions EBS Stock Holding History

DSC Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-36,000	Closed	-$809K	–	78
2014 Q2	$809K	Buy	+36,000	New	+$838K	0.43%	36

Other funds holding EBS

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

DSC Advisors's EBS Position: Q3 2014 in Review

DSC Advisors sold out of Emergent Biosolutions (EBS) in Q3 2014, closing a stake of 36,000 shares — an estimated $809K sold.

DSC Advisors first reported a position in EBS in Q2 2014 and held it in 1 quarter. The position peaked at $809K in Q2 2014. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2014.

DSC Advisors reported no remaining Emergent Biosolutions position as of Q3 2014 after selling out during the quarter.
DSC Advisors sold 36,000 Emergent Biosolutions shares in Q3 2014, an estimated $809K.
DSC Advisors first reported a position in Emergent Biosolutions in Q2 2014 and held it in 1 quarter.
DSC Advisors's Emergent Biosolutions position peaked at $809K in Q2 2014.
162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2014.

Based on DSC Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.